Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Revium Recovery Inc. (RVRC)
Irvine, CA, US
Operating from its Irvine, California headquarters, Revium Recovery Inc. is a United States-based entity engaged in the production and commercialization of an extensive portfolio of both alcoholic and non-alcoholic drinks. Its product catalog features a variety of specialized waters (structured and flavored), a selection of sports and energy beverages, green tea, and a range of spirits. The company also holds a significant strategic collaboration with Quantum TecH20. This enterprise, initially named OC Beverages, Inc., rebranded to Revium Recovery Inc. in December of 2020.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +11.33% | +221.15% | +221.15% | +234.00% | +11.33% | -1.76% | +122.67% | -96.29% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Medical - Healthcare Information Services: +14.2%—
-
EPS growth Medical - Healthcare Information Services: +43.1%-145.9% Q2'25: +17.7% (vs Q2'24)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%—
-
EBIT margin Medical - Healthcare Information Services: +8.8%—
-
ROIC Medical - Healthcare Information Services: +5.2%-25.7% Q2'25: 0.0% (vs Q2'24)
-
Share dilution Medical - Healthcare Information Services: -0.1%+106.9% Q2'25: -99.8% (vs Q2'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×0.00× Q2'25: -0.27× (vs Q2'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | A- | 4/5 | 2/5 | 2/5 | 4/5 | 4/5 | 4/5 | 5/5 |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Inna Martin | President, Chief Operating Officer, Secretary & Director | 271.5K | female |
| Amir Avraham | Chief Executive Officer | 91.0K | male |
| Arie Gordashnikov | Chief Financial Officer & Treasurer | 53.5K | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RVRC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
